Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Aandeel Pharming Group AEX:PHARM.NL, NL0010391025

  • 0,741 17 jun 2024 17:35
  • 0,000 (0,00%) Dagrange 0,734 - 0,750
  • 3.705.208 Gem. (3M) 6M

Pharming mei 2018

9.480 Posts
Pagina: «« 1 ... 301 302 303 304 305 ... 474 »» | Laatste | Omlaag ↓
  1. [verwijderd] 18 mei 2018 14:10
    quote:

    LabraDoortje schreef op 18 mei 2018 14:08:

    [...]

    Helemaal eens. En ik vind dat zo ontzettend jammer.

    Is nu bijna voor elk aandeel zo, het beste is niet goed genoeg, bij uitstekende cijfers zakt het aandeel en voor de rest kan je nog enkel een gokje wagen waar het dan meestal slecht bij afloopt.
  2. Vriendelijke 18 mei 2018 14:14
    METHOD FOR PREVENTING PHISHING AND PHARMING BY USING PORTAL SITE

    Application No.
    EP15905909
    Publication No.
    WO2017061668
    Applicant
    Kim, Yoon Jeong
    Representative
    ...
    IPC
    H04L29/06
    H04L29/08
    DEVICE AND METHOD FOR PREVENTING PHARMING ATTACK BY USING DNS MODULATION

    Application No.
    EP16830684
    Publication No.
    WO2017018651
    Applicant
    Soosan Int Co., Ltd.
    Representative
    ...
    IPC
    H04L29/06
    H04L29/12
    MILKING DEVICE

    Application No.
    EP12702328
    Publication No.
    EP2665356
    Applicant
    Pharming Intellectual Property B.V.
    Representative
    Nederlandsch Octrooibureau
    IPC
    A01J5/04
    USE OF ANTICOAGULANTS IN THE PRODUCTION OF RECOMBINANT PROTEINS IN THE MILK OF TRANSGENIC ANIMALS

    Application No.
    EP11712029
    Publication No.
    EP2547337
    Applicant
    Pharming Intellectual Property B.V.
    Representative
    Nederlandsch Octrooibureau
    IPC
    A61K31/37
    C07K14/75
    C12N15/85
    (+2)
    Use of C1 inhibitor for the prevention of ischemia-reperfusion injury

    Application No.
    EP11172880
    Publication No.
    EP2380587
    Applicant
    Pharming Intellectual Property B.V.
    Representative
    Nederlandsch Octrooibureau
    IPC
    A61K38/57
    A61K45/06
    A61P41/00
    (+1)
    TREATMENT OF BLEEDING WITH LOW HALF-LIFE FIBRINOGEN

    Application No.
    EP09739029
    Publication No.
    EP2285400
    Applicant
    Laboratoire Français du Fractionnement et des Biotechnologies
    Representative
    Regimbeau
    IPC
    A61K38/36
    A61P7/04
    COMPOSITE MATERIAL COMPRISING FIBRINOGEN AND BIOACTIVE GLASS AS A WOUND DRESSING

    Application No.
    EP07789281
    Publication No.
    EP2054091
    Applicant
    Novathera Limited
    Pharming Group NV
    Representative
    Swinkels, Bart Willem
    IPC
    A61L26/00
    COMPOSITE MATERIAL

    Application No.
    EP07789283
    Publication No.
    EP2054092
    Applicant
    Novathera Limited
    Pharming Group NV
    Representative
    Swinkels, Bart Willem
    IPC
    A61L26/00
    A61L27/10
    A61L27/32
    (+8)
    Method for detecting DNS redirects or fraudulent local certificates for SSL sites in pharming/phishing schemes by remote validation and using a credential manager and recorded certificate attributes

    Application No.
    EP08159776
    Publication No.
    EP2020798
    Applicant
    SYMANTEC CORPORATION
    Representative
    D Young & Co LLP
    IPC
    H04L29/06
    CLIENT SIDE PROTECTION AGAINST DRIVE-BY PHARMING VIA REFERRER CHECKING

    Application No.
    EP08155808
    Publication No.
    EP1990977
    Applicant
    SYMANTEC CORPORATION
    Representative
    Meldrum, David James, et al
    IPC
    H04L29/06
    H04L29/08
    G06F21/00
    USE OF C1 INHIBITOR FOR THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY

    Application No.
    EP06824316
    Publication No.
    EP1965831
    Applicant
    Pharming Intellectual Property B.V.
    Representative
    Swinkels, Bart Willem, et al
    IPC
    A61K38/57
    A61P9/10
    A61P41/00
    SYSTEM AND METHOD OF MOBILE ANTI-PHARMING AND IMPROVING TWO FACTOR USAGE

    Application No.
    EP06705665
    Publication No.
    WO2006086929
    Applicant
    Metaswarm (HongKong) Ltd.
    Representative
    ...
    IPC
    H04L9/32
    Purification of alpha-1 proteinase inhibitor

    Application No.
    EP06021520
    Publication No.
    EP1736483
    Applicant
    Pharming Intellectual Property BV
    Representative
    ten Haaft, Petrus, et al
    IPC
    C07K14/81
    Nematocides

    Application No.
    EP05702143
    Publication No.
    EP1711061
    Applicant
    Pharming Limited
    Representative
    Johnson, Yvonne Catherine
    IPC
    A01N65/00
    C1 INHIBITOR WITH SHORT HALF-LIFE FOR TRANSIENT TREATMENT

    Application No.
    EP04748575
    Publication No.
    EP1626736
    Applicant
    Pharming Intellectual Property B.V.
    Representative
    Nederlandsch Octrooibureau
    IPC
    A61K38/57
    A61P1/18
    A61P9/00
    (+5)
    PROTEIN MODIFICATION

    Application No.
    EP03756757
    Publication No.
    EP1551987
    Applicant
    Pharming Intellectual Property B.V.
    Representative
    van Westenbrugge, Andries, et al
    IPC
    C12P21/00
    C12P21/02
    C12P19/00
    (+3)
    Pharmaceutical compositions comprising recombinant human acid alpha-glucosidase containing mannose 6-phosphate

    Application No.
    EP02018187
    Publication No.
    EP1262191
    Applicant
    Pharming Intellectual Property BV
    Erasmus Universiteit Rotterdam
    Academic Hospital Rotterdam
    Representative
    Renes, Johan
    IPC
    A61K38/47
    A01K67/027
    C12N15/56
    (+2)
    HUMAN C1 INHIBITOR PRODUCED IN THE MILK OF TRANSGENIC MAMMALS

    Application No.
    EP01906428
    Publication No.
    EP1252184
    Applicant
    Pharming Intellectual Property B.V.
    Representative
    van Westenbrugge, Andries, et al
    IPC
    C07K14/47
    FUSION PROTEINS INCORPORATING LYSOZYME

    Application No.
    EP00940625
    Publication No.
    EP1194570
    Applicant
    Pharming Intellectual Property BV
    Representative
    Chapman, Paul William, et al
    IPC
    C12N15/62
    C12N15/00
    A01K67/027
    (+4)
    TREATMENT OF POMPE'S DISEASE

    Application No.
    EP99965162
    Publication No.
    EP1137762
    Applicant
    Genzyme Corporation
    Representative
    Adams, Harvey Vaughan John, et al
    IPC
    C12N9/24
    A01N37/18
    A61K38/43
    (+1)
9.480 Posts
Pagina: «« 1 ... 301 302 303 304 305 ... 474 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium

De markt kijkt niet verder dan zijn neus lang is bij Pharming

Het laatste advies leest u als abonnee van IEX Premium

Inloggen Word Abonnee

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links